Part 1: Evolving Understanding of Pathophysiology and Modern Proposed Framework of Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
Part 1: Suspicion, Identification, and Evaluation of Patients Who May Have Early Alzheimer’s Disease Neurobiology |
|
Enduring |
|
$0.00 |
Part 2: Current Treatments and Rising Phase 3 Disease-Modifying Therapies |
|
Enduring |
|
$0.00 |
Part 2: Importance and Implications of Biomarkers in Diagnosis and Modern Treatment of Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
Part 3: Diagnostic and Therapeutic Monitoring Strategies and their Potential Role in the Future of Disease-Modifying Therapy for Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
Part 3: Evolving Roles in Alzheimer’s Disease Management: Team-Based Care in the Modern Age of Disease-Modifying Therapy |
|
Enduring |
|
$0.00 |
Pay It Forward: Bridging the Gaps Between Payers and Providers to Get the Medication Your Patient Needs When They Need It for Narcolepsy and... |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Attendance
|
Enduring |
|
$0.00 |
Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) --... |
|
Enduring |
|
$0.00 |
Stronger Together: Leveraging Evidence-Based Patient Collaboration and Treatment Strategies to Streamline Success in Multiple Sclerosis |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
|
Enduring |
|
$0.00 |
The Frontline of Alzheimer's Care: Addressing Real Questions from Clinicians in the New Dawn of Disease-Modifying Therapy |
|
Enduring |
|
$0.00 |
The Hidden Side of Multiple Sclerosis: Harnessing Key Pathologies to Improve Outcomes Across the Multiple Sclerosis Spectrum |
|
Live |
05/30/2024 - 8:00am EDT |
$0.00 |
The Path of Least Resistance: New Agents and Emerging Strategies for Managing Childhood-Onset and Refractory Epilepsies (Credit Expired) |
|
Enduring |
|
$0.00 |
Thinking Through ARIA: A Case-Based Exploration of Recognition, Evaluation, and Reporting of Novel Imaging Events of Alzheimer's Therapeutics |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
|
Enduring |
|
$0.00 |
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Closing Module |
- 0.50 AMA PRA Category 1 Credit™
- 0.50 AAPA Category I CME
- 0.50 Attendance
|
Enduring |
|
$0.00 |
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Emergency Medicine Module |
- 0.50 AMA PRA Category 1 Credit™
- 0.50 AAPA Category I CME
- 0.50 Attendance
|
Enduring |
|
$0.00 |